MUC1 and renal cell carcinoma: In recent years, new discoveries on the structure and function of MUC1 as well as the continuous development of research techniques have greatly propelled the development of research strategies targeting MUC1 as a therapeutic target, and antitumor vaccines targeting MUC1 have begun to be used in the treatment of advanced RCC [94].